BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8804003)

  • 1. New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients.
    Krautzig S; Linnenweber S; Schindler R; Shaldon S; Koch KM; Lonnemann G
    Nephrol Dial Transplant; 1996; 11 Suppl 2():87-91. PubMed ID: 8804003
    [No Abstract]   [Full Text] [Related]  

  • 2. Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens.
    Lonnemann G
    Kidney Int Suppl; 1993 Jun; 41():S195-200. PubMed ID: 8320919
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyrogen transfer across PMMA membranes.
    Cappelli G; Ballestri M; Di Felice A; Bonucchi D; Albertazzi A
    Contrib Nephrol; 1999; 125():233-9. PubMed ID: 9895445
    [No Abstract]   [Full Text] [Related]  

  • 4. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
    Lonnemann G; Schindler R
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality of water and dialysate in haemodialysis.
    Lonnemann G; Krautzig S; Koch KM
    Nephrol Dial Transplant; 1996 Jun; 11(6):946-9. PubMed ID: 8671945
    [No Abstract]   [Full Text] [Related]  

  • 6. Should ultra-pure dialysate be mandatory?
    Lonnemann G
    Nephrol Dial Transplant; 2000; 15 Suppl 1():55-9. PubMed ID: 10737168
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodialysis and water quality.
    Coulliette AD; Arduino MJ
    Semin Dial; 2013; 26(4):427-38. PubMed ID: 23859187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-flux dialyzers, backfiltration, and dialysis fluid quality.
    Schiffl H
    Semin Dial; 2011; 24(1):1-4. PubMed ID: 21299628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriological water quality in the central dialysis fluid delivery system from the survey of the Japanese Society for Dialysis Therapy.
    Masakane I; Takemoto Y; Nakai S; Tsubakihara Y; Akiba T; Watanabe Y; Iseki K
    Blood Purif; 2009; 27 Suppl 1():11-6. PubMed ID: 19556757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study.
    Hasegawa T; Nakai S; Masakane I; Watanabe Y; Iseki K; Tsubakihara Y; Akizawa T
    Am J Kidney Dis; 2015 Jun; 65(6):899-904. PubMed ID: 25641063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When good water goes bad: how it happens, clinical consequences and possible solutions.
    Lonnemann G
    Blood Purif; 2004; 22(1):124-9. PubMed ID: 14732820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis therapy.
    Pastan S; Bailey J
    N Engl J Med; 1998 May; 338(20):1428-37. PubMed ID: 9580651
    [No Abstract]   [Full Text] [Related]  

  • 13. [The passage of bacteria and bacterial metabolites through hemodialysis membranes].
    Botzenhart K; Köchling W
    Arch Hyg Bakteriol; 1971 Apr; 154(5):474-9. PubMed ID: 4996180
    [No Abstract]   [Full Text] [Related]  

  • 14. How should dialysis fluid be individualized for the chronic hemodialysis patient? Sodium.
    Flanigan MJ
    Semin Dial; 2008; 21(3):226-9. PubMed ID: 18363598
    [No Abstract]   [Full Text] [Related]  

  • 15. [Febrile reactions during hemodialysis].
    Dutz W; Fabian R; Hiller R
    Z Urol Nephrol; 1973 Sep; 66(9):683-8. PubMed ID: 4593073
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances and innovations in dialysis in the 21st century.
    Power A; Duncan N; Goodlad C
    Postgrad Med J; 2009 Feb; 85(1000):102-7. PubMed ID: 19329705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of hemodialysis water: a 7-year multicenter study.
    Laurence RA; Lapierre ST
    Am J Kidney Dis; 1995 May; 25(5):738-50. PubMed ID: 7747728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should dialysis fluid be individualized for the chronic hemodialysis patient? Temperature.
    Selby NM; McIntyre CW
    Semin Dial; 2008; 21(3):229-31. PubMed ID: 18363597
    [No Abstract]   [Full Text] [Related]  

  • 19. Dialysis: Membrane flux, dialysate purity and cardiovascular outcomes.
    Grooteman M; Nubé M
    Nat Rev Nephrol; 2013 Aug; 9(8):439-41. PubMed ID: 23797202
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: which cytokine is a surrogate marker for dialysis-related complications?
    Dinarello CA
    Nephrol Dial Transplant; 1995; 10 Suppl 3():25-8. PubMed ID: 7494610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.